Part IV – ANNEX 1
PRESCRIBED MEDICATION: TACTIS
NAME OF PATIENT
AGE & SEX
CLINICAL AREA/ ROOM NO.
MEDICATIONS TRADE/ GENERIC
DOSE/ ROUTE/ FREQUENCY
PHARMACOLOGICAL CLASSIFICATION
why is the client receiving the drug?
T A
Therapeutic Classification
Antibacterial & Anti-parasitic
: ________________________________________________
: ________________________________________________
: ________________________________________________
: Metronidazole _______________________________
: 500 mg IV q 6________________________________
: antibacterial_________________________________
: For antibacterial_______________________________
C T I S
Action Contraindication Toxic/ Side Effects Interventions Safety
Give oral form w/ meals to
minimize GI distress. 500 mg IV q 6
A direct acting Vertigo, headache, ataxia,
trichomonacide & amebic Contraindicated to irritability, abdominal Tell pt. metallic taste &
idée that works @ both hypersensitivity cramping, in coordination, dark or red brown urine
intestinal & extra intestinal. confusion, nausea, may occur.
vomiting, anorexia,
diarrhea, constipation The IV form should be
administered by slow
infusion only.
Tell pt. to avoid alcohol or
alcohol containing
medications during therapy
& for @ least 48 hours after
therapy is completed.
 T A
Therapeutic Classification/
Name of drugs/ Dosage
Anti - Infectives
Clindamycin Hydrochloride
300 mg IV q 6
Action
Inhibits bacterial protein
synthesis by binding to the
50s subunit of the
ribosome.
C T I S
Contraindication Toxic/ Side Effects Interventions Safety
300 mg IV q 6
Monitor renal, hepatic &
Contraindicated in patient Nausea, vomiting, hematopoietic functions
with known abdominal pain, diarrhea, during prolonged therapy
hypersensitivity to the rash, urticaria .
antibiotic congener Don’t use in meningitis
linomycin.
Instruct pt. to report
adverse reactions to the
doctor especially diarrhea
Advice pt’s taking the
capsule form to take with a
full glass of water to
prevent dysphasia.
Give deep I.M. rotate sites
warn that I.M. injection
may be painful.
 T A
Therapeutic Classification/
Name of drugs/ Dosage
Penicillins
Piperacillin + Tazobactam
2.25 mg IV q 12 ANST (-)
C T I S
Action Contraindication Toxic/ Side Effects Interventions Safety
Before giving pipercillin 2.25 mg IV q 12 ANST (-)
Bacteria against Hypersensitivity to Headache, seizures, ask pt. if he’s any allergic
microorganisms by penicillin’s, cephalosporin’s dizziness, irritability, reactions to penicillin.
inhibiting cell wall or B-Lactamase inhibitors. neuromuscular, nausea,
synthesis during active vomiting Check CBC & platelets
multiplication. Bacteria frequency. Drug may cause
resist penicillin by thrombocytopenia.
producing penicillinases.
Monitor serum potassium
level.
Give I.V. intermittently to
prevent vein irritation
Give piperacillin @ lest 1
hour before bacteriostatic
antibiotics.
 T A C T I S
Therapeutic Classification/ Action Contraindication Toxic/ Side Effects Interventions Safety
Name of drugs/ Dosage
Anti diabetic agent Increase glucose transport Contraindicated to Itching, swelling, redness, Instruct patient about nature 50 – 100 “U “ IV q 6
across muscle & fat cell hypoglycemia IV stinging, warmth @ site of of disease the importance of
Humulin N membranes to reduce blood administration injection following the therapeutic
glucose level. hyperglycemic coma. regimen, adhering to specific
50-100 “U” q 6 diet.

Advise patient to wear

medical identification alert
@ all times.

Instruct patients on proper

use of equipment for
performing self monitoring
of blood glucose.

Check expiration date on

vial before using contents.
 T A C T I S
Therapeutic Classification/ Action Contraindication Toxic/ Side Effects Interventions Safety
Name of drugs/ Dosage

Anti Diabetic Agent Promotes conversion of
glucose to its storage form,
Insulin glycogen; triggers amino
( Ecophene Insulin acid uptake and conversion
Suspension) to protein in muscle cells
and inhibits protein in
degradation.
100 units/ ml in 1.5 ml
cartridge system
Contraindicated to Lip atrophy, itching,
hypoglycemia. swelling, redness, stinging,
anaphylaxis
Use only regular insulin in 100 “U”/ ml in 1.5 ml
patient with circulating cartridge system
collapse, diabetic
ketoacidosis, or
hyperkalemia. Do not use
reg. insulin concentrated I.V.
Advice patient not to alter
the order of mixing insulin’s
or changed the model or
brand of syringe or needle.
Store insulin cool area.
Don’t use insulin that has
changed color or becomes
clumped or granular in
appearance.
Regular insulin should not be
mixed with globins insulin.